Biotechnology News
Cutting edge news about companies engaged in the research and development of new drugs, medical devices and procedures as well as research, books and information on FDA approvals, patents and awards. Biotechnology news highlights the use of biological processes, organisms or systems to manufacture products that improve the quality of life.
Academy Medical and Rennova Health, Inc. Partner to Strengthen Offering in Federally Funded Medical Facilities
Government partnership will expand access to Academy Medical’s product portfolio within the Department of Veterans Affairs (VA), Department of Defense (DoD), and Indian Health Services (IHS) for patients and clinicians. - August 15, 2016 - Academy Medical
CellectCell, Inc. Announces Georgia Research Alliance Phase IIB Funding for the Commercialization of Novel Label-Free Cell Isolation Technology
CellectCell, Inc., a company that develops novel cell isolation and purification technology, announced today the completion of milestones related to its Phase IIA grant and receipt of Phase IIB grant funding from the Georgia Research Alliance (GRA). CellectCell’s initial focus is the... - August 12, 2016 - CellectCell, Inc.
Alfa Scientific Designs Granted OTC/CLIA Waived Status for BUP Drug Test by the Food and Drug Administration
Company now has a total of 15 drug tests that are OTC/CLIA-waived. - August 11, 2016 - Alfa Scientific Designs
Medical Technology and Practice Patterns Institute Announces That It Has Been Awarded an R01 Research Grant by the Agency for Healthcare Research and Quality
The Medical Technology and Practice Patterns Institute, Inc. (MTPPI) announces that it has been awarded an R01 research grant by the Agency for Healthcare Research and Quality (AHRQ). The grant will be used to investigate the impact of the End-Stage Renal Disease Prospective Payment System (ESRD PPS) reform that was enacted by Congress in 2011. - August 11, 2016 - Medical Technology and Practice Patterns Institute
Chinese Pharma Market Prospects Remain Robust as New Drivers Emerge
Despite slowing Chinese pharma market growth to 7.6% in 2015, it remains a high growth spot with numerous emerging opportunity areas, according to the China Pharmaceutical Guide 2016 (11th Edition). Hot off the press, the China Pharmaceutical Guide 2016, an indispensable reference for MNC executives with China responsibilities for over a decade, aims to help proactive HQ and local executives feel the pulse of Chinese healthcare and stay in the driver seat of their business in the country. - August 09, 2016 - WiCON International Group LLC
Marshfield Based Preventiongenetics Earns Accreditation for Global Testing
PreventionGenetics, located in Marshfield, WI has achieved ISO 15189:2012 certification through A2LA. PreventionGenetics is a genetic testing laboratory. - August 06, 2016 - PreventionGenetics
AMTS Expands Life Science Footprint with Acquisition of Validation Specialists
AM Technical Solutions announces the acquisition of Boston-based, Validation Specialists and develops a more focused approach within the Life Sciences Industry. - August 04, 2016 - AM Technical Solutions
Fluorescent Cell Organelle Stains - Free Brochure Launched by MoBiTec GmbH
Fluorescent molecules and conjugates are invaluable tools in modern medical and biological laboratories. Cell-permeant fluorophores help reveal the localization of intracellular organelles and structures in live cells with minimal impairment. - July 30, 2016 - MoBiTec GmbH
PA Biotech Center Companies Showcased to Potential Investors at Second Annual "Entrepreneur Spotlight"
Baruch S. Blumberg Institute hosts Shark Tank-style event at the Pennsylvania Biotech Center, honors Barbara Schilberg, CEO of BioAdvance. - July 29, 2016 - Hepatitis B Foundation
Eli Gilboa, University of Miami, to Present at 7th Non-Coding RNA & RNAi Therapeutics
Eli Gilboa, Professor of Microbiology & Immunology, University of Miami, to present at 7th Non-Coding RNA & RNAi Therapeutics Conference. - July 28, 2016 - GTCbio
What’s the Hype About the Gene Editing Technology CRISPR-Cas9 Without Knowing the DNA Alphabet?
“Every language is based on an Alphabet. Our DNA or genes language is no exception and is based on an Alphabet made of 64 Master DNA Sequences or 64 composite letters,” says Scientist Bob Ainuu Afamasaga. - July 28, 2016 - AIGA
Kevin Morris, from the City of Hope, to Present at 7th Non-Coding RNA & RNAi Therapeutics
Kevin Morris, City of Hope, to discuss “Genomic Dark Matter; The Complexities of Non-Coding RNA from Mechanism to Therapeutics” at Non-Coding RNA & RNAi Conference. - July 27, 2016 - GTCbio
Kepley BioSystems Selected as Finalist for 2016 Hello Tomorrow Global Startup Challenge
Kepley BioSystems announced today that their team has been selected as a Top 500 Startup for the 2016 Hello Tomorrow Challenge. Hello Tomorrow is the world’s leading nonprofit aiming to accelerate science and technology entrepreneurship. Their mission is to catalyze the intersection of top... - July 21, 2016 - Kepley Biosystems Incorporated
Braincure Biotech Study Indicates New Target for Combating Alzheimer’s
A team of researchers led by Sírnir Thorsson has established that the protein GPR3 could be instrumental in relieving cognitive deficits and mitigating the production of "amyloid plaques." - July 21, 2016 - BrainCure Biotech
Braincure Biotech Publishes Two New Reports
With more than 90 medicines in clinical trials or awaiting approval and knowledge of Alzheimer’s increasing, patients and caretakers look towards the future with high spirits. - July 21, 2016 - BrainCure Biotech
Marcus Carr, Vice President at Pfizer to Keynote at GTCbio’s Cell & Gene Therapy Conference
Marcus Carr, Vice President at Pfizer, will give a keynote presentation on, “Clinical Development of Gene Therapy for Hemophilia B” at 3rd Cell & Gene Therapy. - July 21, 2016 - GTCbio
Bioscience Americas Outlines Growth Strategy
Opportunities abound for the world's leading developer of autologous stem cell treatment centers. - July 19, 2016 - Bioscience Americas
Hua Xu, Principal Scientist at Pfizer, to Present at Drug Design & Medicinal Chemistry Mtg
Hua Xu, Worldwide Medicinal Chemistry at Pfizer, to discuss “Chemical Biology Tools for Target Identification” at 11th Drug Design & Medicinal Chemistry Mtg. - July 19, 2016 - GTCbio
How to Commercialize Biosimilars? Case Studies from Boehringer Ingelheim, EMD Serono and Teva
SMi Group reports: Boehringer Ingelheim, EMD Serono and Teva will be presenting at this year’s Biosimilars North America meeting in New Jersey, USA on November 16 - 17. - July 15, 2016 - SAE Media Group
TJ Cradick from CRISPR Therapeutics to Present at GTCbio’s Cell & Gene Therapy Conference
TJ Cradick, Head of Genome Editing at CRISPR Therapeutics, to talk on, “Therapeutic Gene Editing with CRISPR/CAS9” at 3rd Cell & Gene Therapy Mtg - July 14, 2016 - GTCbio
Alfa Scientific Designs, Inc. to Introduce New Products and Driven Flow™ Technology During Exhibition Events in August
Alfa Scientific Designs, Inc., a leader in the development and manufacture of rapid immunoassay point-of-care tests, will be introducing its newest products featuring Driven Flow™ Technology during August at summer tradeshow events across the U.S. While attending the 68th American Association... - July 13, 2016 - Alfa Scientific Designs
Erin Keaney, at Novartis, to Present at Drug Design & Medicinal Chemistry
Erin Keaney, Global Discovery Chemistry at Novartis Institutes for BioMedical Research, will give a presentation at 11th Drug Design & Medicinal Chemistry. - July 12, 2016 - GTCbio
Richard Buller, VP at Pfizer, to Give a Keynote at GTCbio’s Biomarker Summit Europe 2016
Richard E. Buller, VP at Pfizer, will give a keynote presentation at GTCbio’s Biomarker Summit Europe 2016. - July 10, 2016 - GTCbio
Quantgene Achieves Breakthrough in Liquid Biopsy Early Cancer Detection by Combining Machine Learning with Next-Generation PCR
Quantgene announced a breakthrough in early cancer detection with a new approach to detect tumor DNA in standard blood samples that combines proprietary machine learning algorithms with next-generation polymerase chain reaction (PCR) technology. The Quantgene researchers analyzed large sets of... - July 08, 2016 - Quantgene
Dr. Stephen Chang to Present at CNS Diseases World Summit 2016
Dr. Stephen Chang, Vice President of R&D at NYSCF will give a presentation at GTCbio’s CNS Diseases World Summit 2016. - July 06, 2016 - GTCbio
An Update on Neurodegeneration Panel Discussion at CNS Diseases World Summit
Harry M. Tracy, President of NI Research will lead “An Update on Neurodegeneration...” panel at CNS Diseases World Summit 2016. - July 04, 2016 - GTCbio
Prosidyan Announces an Exclusive Joint Collaboration and License Agreement with MO-SCI Corporation for an Exciting New Technology
New Jersey based company Prosidyan, Inc. (www.prosidyan.com), developer of proprietary fiber-based bioactive glass orthobiologics products, announced today that it has entered into an exclusive joint collaboration and license agreement with MO-SCI Corporation of Rolla, Missouri for an exciting new... - June 30, 2016 - Prosidyan, Inc.
Michael Naso, Janssen R&D to Present at GTCbio’s Cell & Gene Therapy Conference
Michael Naso, Janssen R&D will discuss, “The Future of Biotherapeutics” at GTCbio’s 3rd Cell & Gene Therapy - June 30, 2016 - GTCbio
MiTeGen Announces Expansion of Manufacturing and R&D Facilities
MiTeGen LLC, a provider of innovative consumables for protein crystallization and X-ray diffraction to academic, pharmaceutical, industrial and government researchers around the world, announced facility expansions which include space for manufacturing of a new line of automated high-speed cryocooling devices, as well as dedicated areas for the manufacturing of CrystalDirect™ crystallization plates. - June 29, 2016 - MiTeGen, LLC
Judy Lieberman, Harvard Medical School to Keynote at Non-Coding RNA & RNAi Therapeutics
Judy Lieberman, Professor of Pediatrics at Harvard Medical School, will give a keynote presentation at GTCbio’s 7th Non-Coding RNA & RNAi Therapeutics Conference. - June 29, 2016 - GTCbio
Alfa Scientific Designs, Inc. Issued Patent for Driven Flow™ Technology
Patent covers new, high-accuracy diagnostic tool that delivers testing results in seconds. - June 28, 2016 - Alfa Scientific Designs
Spaulding Clinical to Disrupt Cardiac Safety Industry with Latest Innovation at DIA 2016
Wireless, hand-held electrocardiograph designed to simplify the collection and transmission of ECG data for Pharmaceutical Sponsors is going to be exhibited at the Drug Informatoin Association's (DIA) 2016 conference. - June 25, 2016 - Spaulding Clinical Research, LLC
Are You Ready for the Fast Approaching Compliance Date for UDI?
Maetrics unveils the current landscape of UDI in the USA and the substantial benefits of early compliance in latest free whitepaper. - June 25, 2016 - Maetrics
Biomarker Market for Diagnostic Applications is Expected to Reach $30.6 Billion Globally by 2020
Biomarkers are novel diagnostic tools that provide intelligence to physician about disease progression and treatment effects. Advancement in understanding of human genome promotes its application in diagnosis of disease on molecular basis. Biomarker technology is evidencing increased application in disease diagnosis, drug development and formulation, diagnosis for exposure of certain harmful chemical and prognostic treatments. - June 19, 2016 - Allied Market Research
Atlantis Health Care Group to Launch Cultural Exchange Program to Develop First Dialysis STEM Platform in Puerto Rico
Atlantis Health Care Group to launch cultural exchange program to develop first dialysis STEM platform in Puerto Rico. Undergraduate pre-licensure nursing students, dialysis patients, High School and Middle School students from the mainland US and Puerto Rico will participate in the first dialysis science, technology, engineering and technology (STEM) educational program pilot. DORADO, Puerto Rico – June 16, 2016 -- Atlantis Health Care Group (AHG), University of Puerto Rico Mayague - June 17, 2016 - Launch Team Consulting
IQ4I Research & Consultancy Published a New Report on “PCR Technologies Global Market – Forecast To 2022”
Polymerase Chain Reaction is a process in which multiple copies of desired DNA sequence is obtained in a short period of time. The factors driving the growth of this market are increasing demand for innovative technology supporting early and accurate diagnosis of life threatening disease, rising demand for PCR in genetic and molecular testing and expiry of key players PCR patents. - June 17, 2016 - IQ4I Research & Consultancy Pvt. Ltd.
Virun® Receives U.S. Patent 9,351,517 for Its Vitamin E, Esolv®, All-the-While Rebranding Itself as a Notable Formulation and Development Giant
Soon after international patent approval, Virun receives U.S. patent 9,351,571 for its principle technology, Esolv®. As research continues to show oils, fats and non-polar compounds have strong and growing efficacious health claims, the need to incorporate these compounds into foods, beverages and supplements will become even more sought-after. VIRUN’s extensive Portfolio, including Esolv®, is accelerating innovation. What Virun has created is notably notable in a noticeable way. - June 16, 2016 - VIRUN
AdvantaPure(R) Offers a New White Paper Focusing on Molded Tubing Connections; Illustrates the Risks and Expenses of Fluid Leaks in Biopharma Manufacturing Operations
Immediately available from high purity tubing manufacturer AdvantaPure is a report titled “How Molded Manifold Assemblies Prevent Leaks and Costly Consequences.” It addresses the risks and costs associated with tubing-to-fitting connection leaks and presents a solution, namely the use of molded connections. The white paper shows how critical leak risk becomes based on the number of connections in a manifold assembly. Additional white papers are available as well. - June 16, 2016 - AdvantaPure
IQ4I Research & Consultancy Published a New Report on “Cell-Free DNA (cfDNA) Testing Global Market – Forecast To 2022”
Cell-free DNA is used to detect chromosomal abnormalities in the foetuses for specific mutations, in cancer patients and graft rejection. During the process, sample with cell-free DNA in different forms are analyzed to get rapid and accurate results for early disease diagnosis. - June 13, 2016 - IQ4I Research & Consultancy Pvt. Ltd.
Spaulding Clinical Research Announces Addition to Cardiac Core Lab Management Team
Shane Braninburg joins cardiac safety solutions team to support growth initiatives. - June 09, 2016 - Spaulding Clinical Research, LLC
Spaulding Clinical Receives FDA 510(k) Clearance for 12-Lead ECG Device
With the FDA 510(k) Clearance for the 12-Lead ECG device - the Spaulding Clinical Electrocardiograph 2100iQ , Spaulding Medical, LLC can continue being the innovation leader in cardiac safety for patients, partners, and physicians. - June 02, 2016 - Spaulding Clinical Research, LLC
Healthcare Executive Search Company, Berke Executive Search, Announces Chronic Obstructive Pulmonary Disease Market to Face Challenges in 2016 and Beyond
At the end of 2015, experts assessed the global market for Chronic Obstructive Pulmonary Disease (COPD) treatments. Their analysis showed strong growth in the sector, with total research funding set to increase on a compounded annual rate of 2.9 percent, reaching $11.2 billion by 2021. Interest in the disease sparked a steady increase in executive searches for candidates with experience in the field. - June 02, 2016 - Berke Executive Search
BÜHLMANN Laboratories AG Announces New Health Canada License for the BÜHLMANN fCAL® turbo Assay
BÜHLMANN Laboratories AG's immunoturbidimetric assay for fecal calprotectin quantification, BÜHLMANN fCAL® turbo is now commercially available in Canada and is Health Canada licensed. - May 24, 2016 - BUHLMANN Diagnostics Corp
ValueCentric’s Training Conference, Focus 2016, Sells-Out in Record Time
ValueCentric, the leader in healthcare channel intelligence, today announced their annual user-training conference, being held in Princeton, NJ May 24th and 25th, has sold out. Anticipation for this event has accelerated with the company’s expanded data service offerings, a significant... - May 20, 2016 - ValueCentric
TriFoil Installs Russia’s First 3D Optical Imager in Novosibirsk
In February 2016, TriFoil Imaging in collaboration with GenMedica Baltic Ltd and assistance of BioVitrum Ltd installed Russia’s first 3D Optical imaging system, the InSyTe FLECT/CT. The system was installed under the operation of Prof. Evgeny Zavyalov, head of SPF Vivarium Department of... - May 17, 2016 - TriFoil Imaging
Robert W. Mcintosh, Ph.D. Recognized as One of the Top 10 Men of the Year by Strathmore's Who's Who Worldwide Publication
Robert W. McIntosh, Ph.D. of Pearl City, Hawaii has been recognized as one of the Top 10 Men of the Year for 2016 by Strathmore’s Who’s Who Worldwide for his outstanding contributions and achievements in the fields of research and development in basic neurosciences and governmental... - May 12, 2016 - Strathmore Worldwide
Jivana Biotechnology Inc Adds Dr David Jablons to Its Advisory Committee
Dr David Jablons Brings Thoracic Surgical Oncology and Lung Cancer Drug Development Experience to The Jivana Advisory Committee. - May 06, 2016 - Jivana Biotechnology Inc
Emport LLC Introduces AlerTox Sticks Mustard Rapid Allergen Test Kit
The AlerTox Sticks line of easy, on-site allergen detection kits now includes a test especially for mustard: AlerTox Sticks Mustard. The kit is designed for food manufacturers whose foods, beverages and surfaces may become contaminated with mustard. - May 02, 2016 - Emport, LLC
Morgan's Fund Issues Statement on Selection for NORD's Natural History Studies Project
A statement was issued today by Stephanie M. Vaughan, Co-founder and President of The Morgan Leary Vaughan Fund (Morgan’s Fund), regarding the announcement of the National Organization for Rare Disorders’ (NORD) selection of Natural History Studies Project participants. - April 22, 2016 - The Morgan Leary Vaughan Fund, Inc.
Michael Seaman of Harvard to Give Keynote at GTCbio’s Antiviral Drugs Conference
Harvard’s Michael Seaman talk is entitled “Choosing Optimal Combinations of Broadly Neutralizing Antibodies for Prevention and Treatment of HIV-1 Infection.” - April 22, 2016 - GTCbio